A CD25×TIGIT bispecific antibody induces anti-tumor activity through selective intratumoral Treg cell depletion
Xin Wei, Linlin Zhao, Fang Yang, Yajing Yang, Huixiang Zhang, Kaixin Du, Xinxin Tian, Ruihua Fan, Guangxu Si, Kailun Wang, Yulu Li, Zhizhong Wei, Miaomiao He, Jianhua Sui
Topics & Concepts
TIGITMonoclonal antibodyEffectorIL-2 receptorAntibodyTreg cellCancer researchRegulatory T cellImmunologyT cellBiologyChemistryImmune systemCAR-T cell therapy researchT-cell and B-cell ImmunologyImmunotherapy and Immune Responses